FDA Drug recall D-0261-2023
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 6…
- FDA Drug
- Class II
- terminated
- Published 2023-02-08
On 2023-02-08 the FDA classified a Class II recall of Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 6… by Discovery Pharma, citing CGMP deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0261-2023 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-11-09 |
| Published | 2023-02-08 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Discovery Pharma |
| Distribution | CA, FL, WA |
Product
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
Reason
CGMP deviations
Identifiers
| upc | 860322001808 |
|---|---|
| code_info | Lots: 22123 Exp. 01/2024; 21732 Exp. 07/2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0261-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.